Turenne Capital
Turenne Capital (Turenne Groupe) is an independent French private equity management firm founded in 1999, operating multi-sector specialized funds across healthcare, hospitality, environment, industry, and deep tech for French small and mid-cap companies, with €3B AUM targeted by 2027.
- Company typePrivate
- Founded1999
- HeadquartersParis, France
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Turenne Capital does
Turenne Capital (doing business as Turenne Groupe) is an independent French private equity management firm founded in 1999 and headquartered in Paris, operating as a multi-fund, multi-sector investment platform. The group manages assets through three AMF-approved portfolio management companies: Turenne Capital Partenaires (GP 99038, est. 1999), Nord Capital Partenaires (GP 10000039, est. 2010), and Innovacom Gestion (GP 00017, est. 2000). It serves two client bases: institutional and private LPs who subscribe to its specialized investment funds, and small-to-mid-cap portfolio companies across France that receive growth capital, LBO financing, and capital transmission solutions.
The firm's product surface is organized into specialized verticals: Capital Santé (healthcare, including Capital Santé 1/2/3 and Next Health Capital), Turenne Hôtellerie (hospitality, with three fund vintages operating 8+ hotel properties), Turenne Emergence (environment and energy), Innovacom (deep tech and industrial startups), Nord Capital (regional Northern France), Nov Relance Impact (ESG-focused), and Femtech Île-de-France (women's health, launched 2026). Ticket sizes typically range from €10-30M for healthcare and €1-5M for venture-stage investments. The group holds 25+ active portfolio companies including DEMGY Group (aerospace plastics), KALI ENVIRONNEMENT (environmental TIC), TSA Industries (industrial stainless steel), and a healthcare portfolio that has produced 18 exits averaging approximately 3X returns over five years.
Revenue is generated through traditional PE economics: recurring management fees on assets under management across multiple fund vintages plus performance-based carried interest on successful exits. The firm's stated objective is to reach €3 billion in AUM by end of 2027, requiring roughly 2-3x scaling from current estimated AUM. Distribution is conducted through direct relationships with institutional LPs (Bpifrance, FEI, Société Générale Capital Partenaires, regional government partners) and high-net-worth investors via regulated FCPI/FIP vehicles. The platform combines sector-specialized investment teams with regional offices to source and execute transactions across the French mid-market.
Turenne Capital firmographics
Firmographics- Name
- Turenne Capital
- Legal name
- Turenne Capital Partenaires
- Website
- https://turennecapital.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Turenne Capital (Turenne Groupe) is an independent French private equity management firm founded in 1999, operating multi-sector specialized funds across healthcare, hospitality, environment, industry, and deep tech for French small and mid-cap companies, with €3B AUM targeted by 2027.
- Ownership category
- akta.pro rank
Turenne Capital industry classification
Industry- Product category
- Private Equity Management
- NAICS
- Other Financial Investment Activities (5239), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investors, Nec (6799)
- akta.pro primary industry
- UCITS / Liquid Alternatives Fund of Funds (FSAHAKAE)
- akta.pro secondary industry
- Institutional Capital Introduction (LP/Family Office/Endowment Matching) (FSAEALAI)
Keywords
Where Turenne Capital is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Turenne Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
Revenue model
- Fund Management Fees: Management fees charged on assets under management across multiple specialized investment funds (Capital Santé, Turenne Hôtellerie, Turenne Emergence, Nord Capital, Innovacom)
- Carried Interest (Performance Fees): Performance-based carried interest from successful fund exits and portfolio company value creation
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Turenne Capital product offering
Product offeringCore offering
Turenne Capital is an independent French private equity group that manages multiple specialized investment funds targeting French small and mid-cap companies across healthcare (Capital Santé, Next Health Capital, Femtech Île-de-France), hospitality (Turenne Hôtellerie), energy and environment (Turenne Emergence), industrial SMEs (Nov Relance Impact, SLP Sélection & Opportunités) and deep tech (Innovacom). The firm executes growth capital, LBO and capital transmission transactions, charging management fees on assets under management and carried interest on successful exits.
Product overview
Turenne Capital is an independent private equity group in France offering a multi-fund, multi-sector investment platform. The group manages various specialized investment vehicles including Capital Santé (healthcare), Next Health Capital (healthcare innovation), Turenne Hôtellerie (hospitality), Turenne Emergence (startups/deeptech), Femtech Île-de-France (women's health), Nov Relance Impact (impact), and SLP Sélection & Opportunités (evergreen fund). The investment approach covers capital development, capital transmission, and capital innovation across sectors including healthcare, hospitality, environment, industry, and deeptech. The group operates through multiple entities including Turenne Capital Partenaires, Nord Capital Partenaires, and Innovacom Gestion, managing funds from seed/exit stages through LBOs, with a focus on French small and medium-sized enterprises.
Differentiator
Problem solved
Functional benefit
Brands
- Capital Santé: Healthcare-focused private equity fund series investing in growth and buyout transactions for healthcare companies with ticket sizes of €10-30M
- Turenne Santé
- Turenne Hôtellerie
- Turenne Emergence
- Nord Capital Partenaires
- Innovacom
- Next Health Capital
- Femtech Île-de-France
- Nov Relance Impact
Products and services
- Capital Santé
- Next Health Capital
- Turenne Hôtellerie
- Turenne Emergence
- Femtech Île-de-France
- Nov Relance Impact
- SLP Sélection & Opportunités
- Capital Santé 3
- Innovacom Gestion Fund Platform
- Nord Capital Partenaires Fund Platform
Quantifiable outcome
- Average 3X return on exits over 5 years in healthcare sector
- +1 more outcomes
Companies that use Turenne Capital
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles6 records
Turenne Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Turenne Capital partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered strategic, minor and core.
- Yannick BeucherstrategicFounder of EXEN (biodiversity assessment) who reinvests in KALI ENVIRONNEMENT group and leads the expanded Biodiversity division.
- Université Paris CitéstrategicScientific partner providing research ecosystem, clinical experts, and technology platforms for Femtech portfolio companies. Contributes financial participation and opens research network.
- Valérie PécressestrategicPolitical leader driving creation of first French and European fund dedicated to women's health through Femtech Île-de-France initiative.
- Édouard KaminskistrategicUniversity president driving academic-industry partnership for women's health innovation through iWISH interdisciplinary institute.
- Les EchosminorBusiness media partner covering Turenne Groupe investments and fund activities through editorial coverage.
- Oceania HotelsminorAcquirer of Hôtel d'Anjou from Turenne Hôtellerie portfolio. Family-owned hotel group recognized for operational expertise in French hospitality.
- E.I.S. Aircraft GmbH (DEMGY EIS GmbH)strategicGerman aerospace components company acquired by Demgy Group, strengthening European leadership in high-value plastics for aeronautics sector.
- Inogen Inc.minorAcquirer of portfolio company PhysioAssist, global leader in oxygen therapy. Acquisition enables US market expansion for Simeox respiratory device.
- Claire PoulardcoreInvestment Director joining Turenne Santé with 7+ years healthcare private equity experience from Omnes. Key senior hire supporting fund expansion.
- Vincent FertcoreSerial entrepreneur and former CEO of Ipsogen (sold to Qiagen) and founding director of HalioDx (sold to Veracyte for €260M+). Brings operational and international expertise.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Turenne Capital competitors and assessment
Company assessmentDirect peers
- Eurazeo: Leading French-listed private equity firm with deep mid-market focus across healthcare, consumer, and growth sectors. Directly comparable as a French-headquartered PE manager with healthcare, growth, and brand/consumer verticals operating in similar ticket sizes to Turenne.
- LBO France: Independent French mid-market PE firm managing multiple sector and growth strategies. Closely comparable business model with diversified fund vintages serving French SMEs, competing directly for mid-cap LBO and growth deals.
- Omnes Capital: French PE firm with dedicated healthcare, deep tech, and small-cap strategies. Directly comparable given shared sector overlap (healthcare) and similar mid-market positioning; Omnes is also a co-investor alongside Turenne on deals like Domain Therapeutics.
- Siparex: Independent French mid-market PE group with regional and sector strategies (including ETI mid-cap). Comparable as a multi-fund French PE manager; Siparex is also a co-investor with Turenne on portfolio companies such as Destia.
- MBO Partenaires: Independent French mid-market PE firm specializing in LBO transactions for SMEs and mid-caps. Closely comparable in ticket size, French mid-market focus, and multi-vintage fund structure.
- Capital Croissance: French independent PE firm focused on growth and LBO transactions in French mid-caps. Directly comparable as an independent French mid-market manager competing for similar growth equity and capital transmission deals.
Broad incumbents
- Bpifrance Investissement: French public investment bank and one of the largest PE investors in France. While Bpifrance is an LP and co-investor of Turenne, it also operates direct PE funds in overlapping sectors, making it both a partner and a broad incumbent competitor for French mid-cap deals.
- PAI Partners: Pan-European mid/large-cap PE firm headquartered in Paris. Overlaps with Turenne on French mid-market LBO deals but operates at a meaningfully larger fund size and broader geographic footprint, positioning it as a larger incumbent in the same space.
- Ardian: Major European PE/alternative asset manager with significant mid-market direct PE activity. Comparable as a much larger incumbent player that competes for French and European mid-cap deals while also serving as an LP to smaller managers like Turenne.
Emerging players
- Kurma Partners: Paris-based healthcare and technology-focused PE/venture firm. Comparable given shared healthcare vertical focus and similar French base; Turenne co-invests alongside Kurma on deals like Germitec.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Turenne Capital social profiles
Digital presenceTurenne Capital compliance and trust
Trust signalCompliance2 records
Turenne Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Turenne Capital leadership team
Management profileNumber of profiles
Profiles11 records
Turenne Capital subsidiaries and ownership
Company hierarchySubsidiaries7 records
Turenne Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Turenne Capital M&A and investment
M&A and investmentM&A5 records
Investments54 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Turenne Capital
What does Turenne Capital do?
Turenne Capital is an independent French private equity group that manages multiple specialized investment funds targeting French small and mid-cap companies across healthcare (Capital Santé, Next Health Capital, Femtech Île-de-France), hospitality (Turenne Hôtellerie), energy and environment (Turenne Emergence), industrial SMEs (Nov Relance Impact, SLP Sélection & Opportunités) and deep tech (Innovacom). The firm executes growth capital, LBO and capital transmission transactions, charging management fees on assets under management and carried interest on successful exits.
Is Turenne Capital a public or private company?
Turenne Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Turenne Capital founded?
Turenne Capital was founded in 1999. It employs 51 to 100 people.
Where is Turenne Capital based?
Turenne Capital is headquartered in Paris, France, in the Europe region.
How does Turenne Capital make money?
Two revenue lines are on record. Fund Management Fees are the primary driver. The others are carried Interest (Performance Fees).
Who are Turenne Capital's main competitors?
Direct peers on record are Eurazeo, LBO France, Omnes Capital, Siparex, MBO Partenaires and Capital Croissance. Broad incumbents are Bpifrance Investissement, PAI Partners and Ardian. Kurma Partners is listed as an emerging player.
Does Turenne Capital have an API?
No public API is recorded for Turenne Capital.
What industry is Turenne Capital in?
Turenne Capital's product category is Private Equity Management. Its primary akta.pro industry code is FSAHAKAE, UCITS / Liquid Alternatives Fund of Funds, with a secondary code of FSAEALAI, Institutional Capital Introduction (LP/Family Office/Endowment Matching). Its NAICS code is 5239 and its SIC code is 6799.